Trial intelligence / Profile preview

Alpha-Mangostin Hydrogel Film for RAS

NCT06039774Phase 2Unknown

Sponsor
Universitas Padjadjaran
Start
Dec 2023
Primary completion
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in recurrent aphthous stomatitis (RAS) comparing α-Mangostin Hydrogel Film with Placebo (2 arms). Primary endpoints: Ulcer Size at 7 days and Pain Visual Analogue Scale at 7 days. Status: unknown.

02

Drugs

alpha-Mangostin
03

Conditions

recurrent aphthous stomatitis (RAS)

Beyond the preview

Go deeper on NCT06039774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06039774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call